SBI-115

CAS No. 882366-16-7

SBI-115( —— )

Catalog No. M20784 CAS No. 882366-16-7

SBI-115 is an?antagonist of?TGR5.?SBI-115 decreases hepatic cystogenesis with polycystic liver diseases via inhibiting TGR5.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 43 In Stock
10MG 67 In Stock
25MG 133 In Stock
50MG 209 In Stock
100MG 337 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SBI-115
  • Note
    Research use only, not for human use.
  • Brief Description
    SBI-115 is an?antagonist of?TGR5.?SBI-115 decreases hepatic cystogenesis with polycystic liver diseases via inhibiting TGR5.
  • Description
    SBI-115 is an?antagonist of?TGR5.?SBI-115 decreases hepatic cystogenesis with polycystic liver diseases via inhibiting TGR5.
  • In Vitro
    SBI-115 (100-200 μM, 24 hours) inhibits proliferation triggered by pre-treatment of cystic cholangiocytes with Taurolithocholic acid (TLCA) in shRNA-transfected ADPKD cholangiocytes. Cell Proliferation Assay Cell Line:shRNA-transfected ADPKD cholangiocytes Concentration:100, 200 μM Incubation Time:24 hours Result:Inhibited proliferation (by 32-48%) triggered by pre-treatment of cystic cholangiocytes with TLCA.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    GPCR19
  • Recptor
    TGR5
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    882366-16-7
  • Formula Weight
    340.78
  • Molecular Formula
    C14H13ClN2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:150 mg/mL (440.17 mM)
  • SMILES
    CCS(=O)(=O)c1ncc(Cl)c(C(=O)Oc2cccc(C)c2)n1
  • Chemical Name
    4-Pyrimidinecarboxylic acid 5-chloro-2-(ethylsulfonyl)- 3-methylphenyl ester

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Masyuk TV Masyuk AI Lorenzo Pisarello Met al.TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases through cyclic adenosine monophosphate/Gαs signaling[J].Hepatology. 2017 Oct;66(4):1197-1218.
molnova catalog
related products
  • SBI-115

    SBI-115 is an?antagonist of?TGR5.?SBI-115 decreases hepatic cystogenesis with polycystic liver diseases via inhibiting TGR5.

  • L-692429

    L-692429 (MK-0751) is a potent nonpeptidyl growth hormone secretagogue (GHS) agonist and benzolactam derivative, known for reversing glucocorticoid-induced inhibition of GH secretion.

  • TGR5

    TGR5 Receptor Agonist, a potent TGR5(GPCR19) agonist, showed improved potency in the U2-OS cell assay (pEC50 = 6.8) and in melanophore cells (pEC50 = 7.5).